$15M Deal Secures Alabama’s Amazonby Terry Bingman 13.02.2024The Nature Conservancy in Alabama has secured over 7,900 acres of land, known as "America's Amazon," in a $15+ million ...
Rising Energy Prices and Inflation Concernsby Terry Bingman 13.02.2024Energy prices, which have been dragging down inflation, may soon reverse the trend. Gasoline prices are starting to rise and ...
Textron Surges on Jefferies’ Price Bumpby Mark Eisenberg 13.02.2024Jefferies raises price target for Textron Inc. after positive developments highlighted in its 10-K report, reaffirming a Buy rating. Optimism ...
Kraken Eyes Crypto Custody: Coin Dominance?by John Darbie 13.02.2024US cryptocurrency exchange Kraken is considering entering the crypto exchange-traded fund (ETF) custody market as it awaits the approval of ...
The Magnificent Seven: Dominating Stocks or Market Risk?by Mark Eisenberg 13.02.2024The concentration of the "Magnificent Seven" stocks in the S&P 500 raises concerns about market concentration and their impact on ...
VOQUEZNA Inclusion in Express Scripts: Game Changer for GERD?by Mark Eisenberg 13.02.2024Phathom Pharmaceuticals' drug VOQUEZNA for Erosive GERD has been included in Express Scripts' formularies, providing relief to millions of patients. ...
NEST Center: Biotech’s Big Leapby Lilu Anderson 13.02.2024The Northeast Science and Technology Center in New Jersey is transforming into a major biotech hub through a strategic partnership. ...
GLAAD Report: LGBTQ Gamers Surge 17%by Lilu Anderson 13.02.2024A GLAAD report reveals that 17% of gamers identify as LGBTQ, up from 10% in 2020. LGBTQ gamers demonstrate similar ...
Shell Expands Reach in New Mexico with Brewer Buyoutby Mark Eisenberg 13.02.2024Shell Mobility is expanding its US retail network with the acquisition of Brewer Oil Co.'s 45-unit network in New Mexico. ...
Adial Pharmaceuticals Targets $40B Addiction Marketby Mark Eisenberg 13.02.2024Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...